4.6 Article

Characterization of the human PANK2 promoter

Journal

GENE
Volume 465, Issue 1-2, Pages 53-60

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.gene.2010.06.011

Keywords

Pantothenate kinase; hnRNPA/B; FOXN4; NF-Y; PKAN

Funding

  1. National Institute of Child Health and Human Development
  2. National Eye Institute
  3. NBIA Disorders Association
  4. Huebner Family Pediatric Neurobiology of Disease Fellowship
  5. Oregon Opportunity
  6. NIH [5P30CA069533, 5P30EY010572]

Ask authors/readers for more resources

Pantothenate kinase 2 (PANK2) is an essential regulatory enzyme in coenzyme A biosynthesis. PANIC mutations cause pantothenate kinase-associated neurodegeneration (PKAN), which leads to pigmentary retinopathy, progressive dystonia and other abnormalities. Two nearly identical PANK2 isoforms have been described: short PANK2 and mature PANK2, which are processed from a precursor isoform. Since the biological relevance of these isoforms remains unclear, we sought to explore their transcriptional regulation. Here we show that their regulation is distinct and describe a promoter for the short isoform of PANK2. Moreover, we identify potential regulators of PANK2 expression, including NF-Y. FOXN4 and the human heterogeneous nuclear ribonucleoprotein A/B family. These findings validate expression of the short PANK2 isoform and enable predictions about potentially deleterious sequence variants in the regulatory region of this human disease gene. (C) 2010 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available